FDA Approved: RABEPRAZOLE SODIUM — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Rabeprazole sodium from Ascend Laboratories, LLC as an Original Application (ANDA 208644), authorizing a generic proton pump inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease

Drugs mentioned

• Rabeprazole sodium (rabeprazole)

Snippet

ORIG AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)